Eli Lilly opens first biotech incubator in China

Eli Lilly has opened its first biotechnology incubator in Beijing, China.

Named the Lilly Gateway Laboratory (LGL), the incubator aims to support early-stage biotech startups by providing plug-and-play labs, shared meeting spaces, and flexible workstations. It can accommodate five to eight companies and their teams.

4B Technologies, a biotech startup focused on therapeutic innovation, is the inaugural tenant of the incubator. Eli Lilly did not disclose details regarding 4B Technologies’ tenancy or any associated investment plans.

Recent Eli Lilly developments

Timeline
13-Mar-2025 💰 AI drug startup Insilico nets $110m series E Insilico Medicine raised $110M in Series E funding Funding supports AI platform and Rentosertib trials
30-Oct-2024 💼 New Alphabet CFO pushes cost efficiency amid earnings growth Anat Ashkenazi is Alphabet’s new CFO. She emphasizes cost efficiency amid rising competition.
18-Nov-2020 💰 Temasek, Sequoia China join Chinese biotech startup’s $200m series A round D3 Bio raises $200M in Series A funding. Funds will enhance oncology and immunology research.

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Recent Eli Lilly developments

Stay ahead in Asia’s tech landscape

Stay updated on the go with our mobile app.